The inhibition of 11β-HSDl indicates that LXR might be involved in suppressing glucocorticoid effects, which might lead to reduce development of obesity and improved insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.